134 related articles for article (PubMed ID: 37890418)
1. A new perspective on isotretinoin in pregnancy: Pregnancy outcomes, evaluation of complex phenotypes, and importance of teratological counselling.
Alay MT; Kalayci A; Seven M
Eur J Obstet Gynecol Reprod Biol; 2023 Dec; 291():148-155. PubMed ID: 37890418
[TBL] [Abstract][Full Text] [Related]
2. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
[TBL] [Abstract][Full Text] [Related]
3. Isotretinoin: Still the cause of anxiety for teratogenicity.
Altıntaş Aykan D; Ergün Y
Dermatol Ther; 2020 Jan; 33(1):e13192. PubMed ID: 31837244
[TBL] [Abstract][Full Text] [Related]
4. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes and factors associated with voluntary pregnancy termination in women who had been treated for acne with isotretinoin.
Yook JH; Han JY; Choi JS; Ahn HK; Lee SW; Kim MY; Ryu HM; Nava-Ocampo AA
Clin Toxicol (Phila); 2012 Dec; 50(10):896-901. PubMed ID: 23116253
[TBL] [Abstract][Full Text] [Related]
6. Face-to-face: isotretinoin use and pregnancy outcome.
Tırmıkçıoğlu Z; Tatlıparmak A
Int J Dermatol; 2024 Feb; 63(2):232-238. PubMed ID: 38095245
[TBL] [Abstract][Full Text] [Related]
7. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy.
De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M
Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381
[TBL] [Abstract][Full Text] [Related]
8. Safety of pregnancy after discontinuation of isotretinoin.
Dai WS; Hsu MA; Itri LM
Arch Dermatol; 1989 Mar; 125(3):362-5. PubMed ID: 2923442
[TBL] [Abstract][Full Text] [Related]
9. Fetal exposure to isotretinoin-an international problem.
Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of isotretinoin exposure during pregnancy.
Dai WS; LaBraico JM; Stern RS
J Am Acad Dermatol; 1992 Apr; 26(4):599-606. PubMed ID: 1597546
[TBL] [Abstract][Full Text] [Related]
11. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.
Loureiro KD; Kao KK; Jones KL; Alvarado S; Chavez C; Dick L; Felix R; Johnson D; Chambers CD
Am J Med Genet A; 2005 Jul; 136(2):117-21. PubMed ID: 15940677
[TBL] [Abstract][Full Text] [Related]
12. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies.
Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG
Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444
[TBL] [Abstract][Full Text] [Related]
13. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
[TBL] [Abstract][Full Text] [Related]
14. Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.
Zomerdijk IM; Ruiter R; Houweling LM; Herings RM; Sturkenboom MC; Straus SM; Stricker BH
BMJ Open; 2014 Nov; 4(11):e005602. PubMed ID: 25392022
[TBL] [Abstract][Full Text] [Related]
15. [Pregnancy after isotretinoin use].
Manders KC; de Vries LC; Roumen FJ
Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
[TBL] [Abstract][Full Text] [Related]
16. Possible long-term teratogenic effect of isotretinoin in pregnancy.
Malvasi A; Tinelli A; Buia A; De Luca GF
Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
[TBL] [Abstract][Full Text] [Related]
17. Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study.
Given JE; Loane M; Garne E; Addor MC; Bakker M; Bertaut-Nativel B; Gatt M; Klungsoyr K; Lelong N; Morgan M; Neville AJ; Pierini A; Rissmann A; Dolk H
BMJ; 2018 Jun; 361():k2477. PubMed ID: 29941493
[TBL] [Abstract][Full Text] [Related]
18. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy and neonatal outcomes after periconceptional exposure to isotretinoin in Koreans.
Cha EH; Kim N; Kwak HS; Han HJ; Joo SH; Choi JS; Chun KC; Kim YA; Koh JW; Han JY
Obstet Gynecol Sci; 2022 Mar; 65(2):166-175. PubMed ID: 35193174
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
